We are live on ! Find out more
NHG

NQ HCIF GP Portfolio holdings

AUM $50.2M
1-Year Est. Return 45.53%
This Fund
S&P 500
This Quarter Est. Return
-22.11%
1 Year Est. Return
-45.53%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$42.1M
AUM Growth
-$12M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVNC
1
DELISTED
Revance Therapeutics, Inc.
RVNC
$42.1M 100%
3,096,650

Similar funds

NQ HCIF GP's Q2 2016 Portfolio in Review

As of Q2 2016, NQ HCIF GP held 1 position worth $42.1M, down 22% from $54.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2016: portfolio turnover was 0%. NQ HCIF GP opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • NQ HCIF GP's ten largest holdings make up 100% of its $42.1M portfolio in Q2 2016.
  • NQ HCIF GP opened 0 new positions and closed 0 in Q2 2016.
  • NQ HCIF GP's portfolio value fell 22% quarter-over-quarter to $42.1M.

Based on NQ HCIF GP's 13F filing for Q2 2016, filed 26 Jul 2016.